PHARMIVA AB

PHARMIVA AB Share · SE0015530670 · A2QRDT (XSTO) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PHARMIVA AB
No Price
Share Float & Liquidity
Free Float 74,97 %
Shares Float 17,31 M
Shares Outstanding 23,09 M
Company Profile for PHARMIVA AB Share
Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. The company is based in Lund, Sweden.

Company Data

Name PHARMIVA AB
Company Pharmiva AB (publ)
Website https://www.pharmiva.com
Primary Exchange XSTO Frankfurt
WKN A2QRDT
ISIN SE0015530670
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Anna Linton
Market Capitalization 13 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Sankt Lars Väg 45B, 22270 Lund
IPO Date 2021-03-31

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB PHARM.ST
More Shares
Investors who hold PHARMIVA AB also have the following shares in their portfolio:
EL. FRANCE 16-28 MTN
EL. FRANCE 16-28 MTN Bond
SFIL 20/23 MTN
SFIL 20/23 MTN Bond